Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in depression in Parkinson's disease.

T A Zesiewicz1, M Gold, G Chari

  • 1Parkinson's Disease and Movement Disorders Center, University of South Florida College of Medicine, Tampa, FL 33606, USA.

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|May 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Wireless multichannel electroencephalography in the newborn.

Journal of neonatal-perinatal medicine·2016
Same author

Measurement of ZZ production in leptonic final states at sqrt[s] of 1.96 TeV at CDF.

Physical review letters·2012
Same author

Search for a Higgs boson in the diphoton final state in pp collisions at sqrt[s]=1.96  TeV.

Physical review letters·2012
Same author

Search for a heavy toplike quark in pp collisions at √s=1.96 TeV.

Physical review letters·2012
Same author

Measurement of polarization and search for CP violation in B(s)0→φφ decays.

Physical review letters·2012
Same author

Measurement of the B(s)0 lifetime in fully and partially reconstructed B(s)0→D(s)(-)(ϕπ(-))X decays in p¯p collisions at √s=1.96 TeV.

Physical review letters·2012
Same journal

Identifying Interpersonal Targets of Predeath Grief: A Reply to Tribhuvan and Phatke.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Postoperative Delirium as a Modifiable Determinant of Cognitive Decline After Hip Fracture Surgery: Implications for Geriatric Psychiatry.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Mediation in a Self-Guided Digital Intervention for Dementia Caregivers Worldwide: Insights and Challenges From the PDC30 Trial.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Reconsidering Outcome Metrics and Clinical Meaning in Late-Life Anxiety Treatment.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Response to "Comment on 'A Systematic Review and Meta-Analysis of Diagnostic Remission, Treatment Response, Attrition and Relapse Following Cognitive Behavior Therapy (CBT), Other Psychological Therapies and Pharmacological Treatments for Anxiety Disorders in Older Adults'".

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same journal

Benefit and Uptake: A Mixed Methods Study Exploring Older Adults' Experiences With a Psychoeducational and Exercise Training Maintenance Intervention.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
See all related articles

Depression is common in Parkinson's disease (PD). Antidepressants may help, but more research is needed to confirm their safety and effectiveness in PD patients, especially regarding motor symptoms.

Area of Science:

  • Neurology
  • Psychiatry
  • Pharmacology

Background:

  • Depression affects a significant portion (40%-50%) of individuals with Parkinson's disease (PD).
  • Current treatment strategies for depression in PD require further investigation and validation.

Purpose of the Study:

  • To summarize current challenges and findings in treating depression among Parkinson's disease patients.
  • To review the existing literature on antidepressant efficacy and safety in the context of PD.

Main Methods:

  • A literature search was conducted using Mednet and manual methods.
  • The review focused on open-label studies, case reports, and existing research on antidepressants in PD.

Main Results:

  • Open-label studies suggest potential efficacy of antidepressants for depression in PD.

Related Experiment Videos

  • Case reports indicate a possible risk of SSRIs worsening motor symptoms, though not confirmed in studies.
  • Serotonin syndrome from combining selegiline and SSRIs appears to be rare.

    • Conclusions:

    • Antidepressants show promise for treating depression in Parkinson's disease.
    • Further rigorous, double-blind studies are essential to confirm safety, efficacy, and impact on motor function.